[HTML][HTML] Prevention and treatment of monkeypox

JG Rizk, G Lippi, BM Henry, DN Forthal, Y Rizk - Drugs, 2022 - Springer
Human monkeypox is a zoonotic orthopoxvirus with presentation similar to smallpox.
Monkeypox is transmitted incidentally to humans when they encounter infected animals …

[HTML][HTML] Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …

Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus …

JG Rizk, A Gupta, P Sardar, BM Henry… - JAMA …, 2021 - jamanetwork.com
Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.

JG Rizk, DN Forthal, K Kalantar-Zadeh, MR Mehra… - Drug discovery today, 2021 - Elsevier
Highlights•Expanded Access (EA) is the use of an investigational drug outside of a clinical
investigation.•Emergency Use Authorizations (EUAs) are issued during public health …

[HTML][HTML] Blood lactate concentration in COVID-19: a systematic literature review

G Carpenč, D Onorato, R Nocini… - Clinical Chemistry and …, 2022 - degruyter.com
Abstract Coronavirus disease 2019 (COVID-19) is an infectious respiratory condition
sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which …

[HTML][HTML] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use associated with reduced mortality and other disease outcomes in US veterans …

JG Rizk, C Wenziger, D Tran, L Hashemi, H Moradi… - Drugs, 2022 - Springer
Objective To determine the association between angiotensin-converting enzyme inhibitors
(ACEIs) or angiotensin II receptor blockers (ARBs) use and coronavirus disease 2019 …

[HTML][HTML] Low-dose aspirin for early COVID-19: does the early bird catch the worm?

JG Rizk, CJ Lavie, A Gupta - Expert Opinion on Investigational …, 2021 - Taylor & Francis
During the ongoing COVID-19 pandemic caused by SARS-CoV-2 virus, the vast majority of
patients have a mild to moderate illness that does not necessitate hospitalization and are …

[HTML][HTML] Against therapeutic anticoagulation in critically ill COVID-19 patients

JG Rizk, CJ Lavie, BM Henry - Seminars in Thrombosis and …, 2023 - thieme-connect.com
There were initially three clear lines of evidence in support of an association between
thrombosis and coronavirus disease 2019 (COVID-19), as caused by SARS-CoV-2 (severe …

[HTML][HTML] To anticoagulate or not to anticoagulate in COVID-19: lessons after 2 years

JG Rizk, A Gupta, JG Lazo Jr, P Sardar… - … in Thrombosis and …, 2023 - thieme-connect.com
A hypercoagulable state associated with coronavirus disease 2019 (COVID-19) has been
well documented and is believed to be strongly supported by a proinflammatory state. The …

[HTML][HTML] Triglycerides and Renal Outcomes According to Albuminuria and in Consideration of Other Metabolic Syndrome Components in Diabetic US Veterans

JG Rizk, JT Hsiung, Y Arif, L Hashemi… - American Journal of …, 2023 - karger.com
Introduction: Hypertriglyceridemia, a component of the metabolic syndrome, is a known
independent predictor of albuminuria and chronic kidney disease (CKD) in the general …